The global Human Fibrin Glue market size was valued at US$ 481.3 million in 2023. With growing demand in downstream market, the Human Fibrin Glue is forecast to a readjusted size of US$ 887.1 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Human Fibrin Glue market. Human Fibrin Glue are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Fibrin Glue. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Fibrin Glue market.
Human Fibrin Glue is a surgical formulation used to create a fibrin clot for hemostasis, cartilage repair surgeries or wound healing. It contains separately packaged human fibrinogen and human thrombin. Human fibrin glues are involved in the process of haemostasis and wound healing. A Human Fibrin Glue (HFG) is made of two components contained in separate vials: a freeze-dried concentrate of clotting proteins, mainly fibrinogen, Factor XIII and fibronectin (the sealant), and freeze-dried thrombin (the catalyst), which is applied to a wound or during the surgery to avoid blood loss, create a clot for haemostasis, decrease the hospital stay with lesser scars.
Key Features:
The report on Human Fibrin Glue market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Human Fibrin Glue market. It may include historical data, market segmentation by Type (e.g., Liquid, Patch), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Fibrin Glue market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Fibrin Glue market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Human Fibrin Glue industry. This include advancements in Human Fibrin Glue technology, Human Fibrin Glue new entrants, Human Fibrin Glue new investment, and other innovations that are shaping the future of Human Fibrin Glue.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Fibrin Glue market. It includes factors influencing customer ' purchasing decisions, preferences for Human Fibrin Glue product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Fibrin Glue market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Fibrin Glue market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Fibrin Glue market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Fibrin Glue industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Fibrin Glue market.
麻豆原创 Segmentation:
Human Fibrin Glue market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Liquid
Patch
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Grifols
Baxter
OMRIX Biopharmaceuticals
Johnson & Johnson(Ethicon)
CSL Limited
Shanghai RAAS
Corza Health
Hualan Biological
Shanghai Xinxing MEDICINE Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Human Fibrin Glue market?
What factors are driving Human Fibrin Glue market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Fibrin Glue market opportunities vary by end market size?
How does Human Fibrin Glue break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Human Fibrin Glue Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Human Fibrin Glue by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Human Fibrin Glue by Country/Region, 2019, 2023 & 2030
2.2 Human Fibrin Glue Segment by Type
2.2.1 Liquid
2.2.2 Patch
2.3 Human Fibrin Glue Sales by Type
2.3.1 Global Human Fibrin Glue Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Human Fibrin Glue Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Human Fibrin Glue Sale Price by Type (2019-2024)
2.4 Human Fibrin Glue Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Human Fibrin Glue Sales by Application
2.5.1 Global Human Fibrin Glue Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Human Fibrin Glue Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Human Fibrin Glue Sale Price by Application (2019-2024)
3 Global Human Fibrin Glue by Company
3.1 Global Human Fibrin Glue Breakdown Data by Company
3.1.1 Global Human Fibrin Glue Annual Sales by Company (2019-2024)
3.1.2 Global Human Fibrin Glue Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Human Fibrin Glue Annual Revenue by Company (2019-2024)
3.2.1 Global Human Fibrin Glue Revenue by Company (2019-2024)
3.2.2 Global Human Fibrin Glue Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Human Fibrin Glue Sale Price by Company
3.4 Key Manufacturers Human Fibrin Glue Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Fibrin Glue Product Location Distribution
3.4.2 Players Human Fibrin Glue Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Fibrin Glue by Geographic Region
4.1 World Historic Human Fibrin Glue 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Human Fibrin Glue Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Human Fibrin Glue Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Human Fibrin Glue 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Human Fibrin Glue Annual Sales by Country/Region (2019-2024)
4.2.2 Global Human Fibrin Glue Annual Revenue by Country/Region (2019-2024)
4.3 Americas Human Fibrin Glue Sales Growth
4.4 APAC Human Fibrin Glue Sales Growth
4.5 Europe Human Fibrin Glue Sales Growth
4.6 Middle East & Africa Human Fibrin Glue Sales Growth
5 Americas
5.1 Americas Human Fibrin Glue Sales by Country
5.1.1 Americas Human Fibrin Glue Sales by Country (2019-2024)
5.1.2 Americas Human Fibrin Glue Revenue by Country (2019-2024)
5.2 Americas Human Fibrin Glue Sales by Type
5.3 Americas Human Fibrin Glue Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Fibrin Glue Sales by Region
6.1.1 APAC Human Fibrin Glue Sales by Region (2019-2024)
6.1.2 APAC Human Fibrin Glue Revenue by Region (2019-2024)
6.2 APAC Human Fibrin Glue Sales by Type
6.3 APAC Human Fibrin Glue Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Fibrin Glue by Country
7.1.1 Europe Human Fibrin Glue Sales by Country (2019-2024)
7.1.2 Europe Human Fibrin Glue Revenue by Country (2019-2024)
7.2 Europe Human Fibrin Glue Sales by Type
7.3 Europe Human Fibrin Glue Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Fibrin Glue by Country
8.1.1 Middle East & Africa Human Fibrin Glue Sales by Country (2019-2024)
8.1.2 Middle East & Africa Human Fibrin Glue Revenue by Country (2019-2024)
8.2 Middle East & Africa Human Fibrin Glue Sales by Type
8.3 Middle East & Africa Human Fibrin Glue Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Fibrin Glue
10.3 Manufacturing Process Analysis of Human Fibrin Glue
10.4 Industry Chain Structure of Human Fibrin Glue
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Fibrin Glue Distributors
11.3 Human Fibrin Glue Customer
12 World Forecast Review for Human Fibrin Glue by Geographic Region
12.1 Global Human Fibrin Glue 麻豆原创 Size Forecast by Region
12.1.1 Global Human Fibrin Glue Forecast by Region (2025-2030)
12.1.2 Global Human Fibrin Glue Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Fibrin Glue Forecast by Type
12.7 Global Human Fibrin Glue Forecast by Application
13 Key Players Analysis
13.1 Grifols
13.1.1 Grifols Company Information
13.1.2 Grifols Human Fibrin Glue Product Portfolios and Specifications
13.1.3 Grifols Human Fibrin Glue Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Grifols Main Business Overview
13.1.5 Grifols Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Human Fibrin Glue Product Portfolios and Specifications
13.2.3 Baxter Human Fibrin Glue Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 OMRIX Biopharmaceuticals
13.3.1 OMRIX Biopharmaceuticals Company Information
13.3.2 OMRIX Biopharmaceuticals Human Fibrin Glue Product Portfolios and Specifications
13.3.3 OMRIX Biopharmaceuticals Human Fibrin Glue Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 OMRIX Biopharmaceuticals Main Business Overview
13.3.5 OMRIX Biopharmaceuticals Latest Developments
13.4 Johnson & Johnson(Ethicon)
13.4.1 Johnson & Johnson(Ethicon) Company Information
13.4.2 Johnson & Johnson(Ethicon) Human Fibrin Glue Product Portfolios and Specifications
13.4.3 Johnson & Johnson(Ethicon) Human Fibrin Glue Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Johnson & Johnson(Ethicon) Main Business Overview
13.4.5 Johnson & Johnson(Ethicon) Latest Developments
13.5 CSL Limited
13.5.1 CSL Limited Company Information
13.5.2 CSL Limited Human Fibrin Glue Product Portfolios and Specifications
13.5.3 CSL Limited Human Fibrin Glue Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CSL Limited Main Business Overview
13.5.5 CSL Limited Latest Developments
13.6 Shanghai RAAS
13.6.1 Shanghai RAAS Company Information
13.6.2 Shanghai RAAS Human Fibrin Glue Product Portfolios and Specifications
13.6.3 Shanghai RAAS Human Fibrin Glue Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Shanghai RAAS Main Business Overview
13.6.5 Shanghai RAAS Latest Developments
13.7 Corza Health
13.7.1 Corza Health Company Information
13.7.2 Corza Health Human Fibrin Glue Product Portfolios and Specifications
13.7.3 Corza Health Human Fibrin Glue Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Corza Health Main Business Overview
13.7.5 Corza Health Latest Developments
13.8 Hualan Biological
13.8.1 Hualan Biological Company Information
13.8.2 Hualan Biological Human Fibrin Glue Product Portfolios and Specifications
13.8.3 Hualan Biological Human Fibrin Glue Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hualan Biological Main Business Overview
13.8.5 Hualan Biological Latest Developments
13.9 Shanghai Xinxing MEDICINE Co., Ltd.
13.9.1 Shanghai Xinxing MEDICINE Co., Ltd. Company Information
13.9.2 Shanghai Xinxing MEDICINE Co., Ltd. Human Fibrin Glue Product Portfolios and Specifications
13.9.3 Shanghai Xinxing MEDICINE Co., Ltd. Human Fibrin Glue Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanghai Xinxing MEDICINE Co., Ltd. Main Business Overview
13.9.5 Shanghai Xinxing MEDICINE Co., Ltd. Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.